EndoQuest Robotics

[PRIVATE]

Service & Cobot Robotics · HQ: Houston, TX · 2 models registered · 6 deployments

New deployment

As of Sep 2026, DEPLOY verifies EndoQuest Robotics: 2 models, 6 deployments across 4 regions, $528.0M raised. 3 sources back the record.

Ownership

PRIVATE

Capital / Funding

$528M

Headquarters

Houston, TX

IP / Patents

Undisclosed

Platform Models

2

Audited Incidents

0

Overview

Houston-based endoluminal robotic surgery company. CEO Eduardo Fonseca. Endoluminal Surgical (ELS) System — flexible robot for scar-free procedures through natural orifices. PARADIGM Trial: FDA-approved final stage (Jan 2026), 50 patients, 5 US centers (Brigham, Mayo, Cleveland Clinic, AdventHealth, HCA). First robotic ESD by gastroenterologist in IDE trial (Oct 2025). Series D-2 co-led by Crescent Enterprises + Dr. Fred Moll (Intuitive surgical co-founder). NVIDIA IGX Thor integration for AI vision. $176M total raised.

Audited Posture AssessmentPeer Percentile: 91.9%

Clean safety record across 6 verified deployments. Limited public funding data for capital position assessment.

  • SURGICAL

Key Facts

ProductEndoluminal Surgical (ELS) System — flexible endoluminal robot
TrialPARADIGM — FDA IDE, 50 patients, 5 US centers (Brigham, Mayo, Cleveland Clinic, AdventHealth, HCA)
FDA StatusFinal stage approved (Jan 2026). First robotic ESD by gastroenterologist (Oct 2025).
Total Funding$176M (Series D-2, Crescent Enterprises + Dr. Fred Moll co-led)
PartnershipNVIDIA IGX Thor integration for AI-powered vision
CEOEduardo Fonseca

Safety & Regulatory Posture

0 entries
Audited Incident & Recall Footprint

No incidents on record for EndoQuest Robotics.

Leadership & Founders

2 entries

Current Program Leadership & Executives

Eduardo Fonsecareported, not verified

CEO

Fred Mollreported, not verified

Series D-2 Co-Lead Investor

Partnerships & Commercial Deployments

3 entries
Total Tracked1
Operating0
Announced1
Concluded0

Key Recurring Partners

NVIDIA1 · 1× joint · 1110 total

Recent Verified Partnerships

  • Partnership

    MOST RECENT

Operator Customers & Fleet Integrators

EndoQuest Robotics - 6 deploymentsEndoQuest Robotics

Platform Models

2 entries

Deployments

6 entries

Sectors & Applications

1 entry

FAQ

13 entries
What is EndoQuest Robotics?

Houston-based endoluminal robotic surgery company. CEO Eduardo Fonseca. Endoluminal Surgical (ELS) System — flexible robot for scar-free procedures through natural orifices. PARADIGM Trial: FDA-approved final stage (Jan 2026), 50 patients, 5 US centers (Brigham, Mayo, Cleveland Clinic, AdventHealth, HCA). First robotic ESD by gastroenterologist in IDE trial (Oct 2025). Series D-2 co-led by Crescent Enterprises + Dr. Fred Moll (Intuitive surgical co-founder). NVIDIA IGX Thor integration for AI vision. $176M total raised.

What does EndoQuest Robotics make?

EndoQuest Robotics has 2 robot models on the DEPLOY registry: Endoluminal Surgical (ELS) System, Endoluminal Robotic Surgical System (EndoQuest Robotics builds physical robots).

Is EndoQuest Robotics publicly traded?

No. EndoQuest Robotics is privately held and not publicly traded, per the DEPLOY registry.

Who competes with EndoQuest Robotics?

On the DEPLOY registry, peer companies to EndoQuest Robotics building in the same form factors include Brainlab, Intuitive Surgical, LEM Surgical, MicroPort MedBot.

Who is the CEO of EndoQuest Robotics?

Eduardo Fonseca is the ceo of EndoQuest Robotics, per the DEPLOY registry.

How can I invest in EndoQuest Robotics?

EndoQuest Robotics is a private company; its shares are not available on public markets, so retail investors cannot buy the stock today. It has raised $528M in disclosed funding.

Where is EndoQuest Robotics headquartered?

EndoQuest Robotics is headquartered in Houston, TX.

How much funding has EndoQuest Robotics raised?

EndoQuest Robotics has raised approximately $528M in disclosed funding on record in the DEPLOY registry.

Who owns EndoQuest Robotics?

EndoQuest Robotics is privately held and venture-backed ($528M raised); ownership sits with its founders and private investors.

Where does EndoQuest Robotics operate robots?

EndoQuest Robotics operates 6 verified deployments, including at Orlando, Florida, USA, Houston, Texas, USA, Cleveland, Ohio, USA.

How many robots has EndoQuest Robotics deployed?

DEPLOY has 6 verified EndoQuest Robotics deployments on record at sites including Orlando, Florida, USA, Houston, Texas, USA, Cleveland, Ohio, USA. That is a count of distinct field deployments each backed by sourced evidence, not a manufacturer's claimed unit total; it updates as new sites are verified.

Is EndoQuest Robotics a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, EndoQuest Robotics ranks in roughly the top 9% of companies tracked by the registry.

Is EndoQuest Robotics safe?

EndoQuest Robotics has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.